Zimmer Biomet Holdings Inc (ZBH) 13F Holders & Ownership Data (909 Funds, Q2 2026)

ZBH ranks #546 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

ZBH is a disclosed holding of Bill Nygren (Harris Associates L.P.), one of the tracked superinvestors on AlphaSMO — it makes up 1.4% of that fund's own 13F portfolio.

909 institutions disclose a position in ZBH, but none treat it as a major bet — even Vestal Point Capital, LP, its most concentrated holder, allocates just 2.8% of its own portfolio to it.

Capital International Investors has added to its ZBH position for two straight quarters, increasing it by $407.9M to reach $1.0B today.

Price T Rowe Associates Inc /md/ has trimmed its ZBH position for two straight quarters, cutting it by $812.8M while still holding $413.0M.

ZBH is up 0.1% today, and institutions have been net buyers of $2.8B this quarter — today's price move and the underlying institutional flow are pointing the same direction.

ZBH posted net income of $806.6M over the trailing twelve months, and currently trades at a P/E of 24.5.

• Profitable — net income of $806.6M over the trailing twelve months
• Revenue grew 8.6% year over year
• Net income declined year over year, from $823.4M to $806.6M
• Generated $1.7B in positive operating cash flow
• Current ratio of 1.98x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.82x equity — within a conventional range